Chemoinformaics analysis of Cholest-5-ene-3,16,22,26-tetrol
| Molecular Weight | 434.661 | nRot | 6 |
| Heavy Atom Molecular Weight | 388.293 | nRig | 20 |
| Exact Molecular Weight | 434.34 | nRing | 4 |
| Solubility: LogS | -4.662 | nHRing | 0 |
| Solubility: LogP | 3.827 | No. of Aliphatic Rings | 4 |
| Acid Count | 0 | No. of Aromatic Rings | 0 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 4 |
| Atoms Count | 77 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 31 | No. of Aromatic Carbocycles | 0 |
| nHetero | 4 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 3 |
| No. of Hydrogen atom | 46 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 27 | No. of Saturated Rings | 3 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
| No. of Oxygen atom | 4 | No. of Arom Bond | 0 |
| nHA | 4 | APOL | 78.9705 |
| nHD | 4 | BPOL | 46.1475 |
| QED | 0.47 |
| Synth | 4.852 |
| Natural Product Likeliness | 3.098 |
| NR-PPAR-gamma | 0.009 |
| Lipinski | Accepted |
| Pfizer | Accepted |
| GSK | Rejected |
| Golden Triangle | Accepted |
| Pgp-inh | 0.001 |
| Pgp-sub | 0.015 |
| HIA | 0.084 |
| CACO-2 | -4.831 |
| MDCK | 0.0000358 |
| BBB | 0.327 |
| PPB | 0.930759 |
| VDSS | 1.155 |
| FU | 0.034709 |
| CYP1A2-inh | 0.02 |
| CYP1A2-sub | 0.524 |
| CYP2c19-inh | 0.009 |
| CYP2c19-sub | 0.508 |
| CYP2c9-inh | 0.053 |
| CYP2c9-sub | 0.33 |
| CYP2d6-inh | 0 |
| CYP2d6-sub | 0.357 |
| CYP3a4-inh | 0.056 |
| CYP3a4-sub | 0.279 |
| CL | 17.991 |
| T12 | 0.091 |
| hERG | 0.014 |
| Ames | 0.023 |
| ROA | 0.57 |
| SkinSen | 0.072 |
| Carcinogencity | 0.078 |
| EI | 0.008 |
| Respiratory | 0.159 |
| NR-Aromatase | 0.019 |
| Antiviral | Yes |
| Prediction | 0.695159 |